The short answer
Gymnema may change insulin requirements, but no protective spacing interval or universal avoidance rule with insulin isophane has been established. Product-specific glucose review is warranted.
What this answer covers
Gymnema sylvestre leaf extract GS4; other extracts, powders and botanical names do not guarantee the same exposure.
- Supplement or preparation
- Gymnema sylvestre
- Medication ingredient
- insulin isophane
An insulin study found a change
A small study adding a particular leaf extract to insulin reported lower insulin requirements and glucose measures. It provides a reason for clinical review when the product changes.
NPH was not identified in the abstract
The inspected abstract does not establish the insulin formulation or a rate of dangerously low glucose. It cannot define the exact risk with isophane or justify a fixed insulin reduction.
There is no tested hour-based solution
The study did not test supplement spacing or compare universal avoidance with monitored use. Its extract-specific results cannot establish a rule for every Gymnema product.
Do not use the study to change insulin
Discuss the exact product and amount with the diabetes team before starting or stopping it. Follow your glucose-monitoring and low-glucose treatment plan. Do not adjust insulin yourself. Human NPH is a subcutaneous suspension; its dosing follows an individual plan.
Evidence and practical considerations
Timing & monitoring
No established spacing interval or universal avoidance rule for this exact preparation with NPH; glucose review remains appropriate.
- Exact scope
- Gymnema sylvestre leaf extract GS4; other extracts, powders and botanical names do not guarantee the same exposure. with Insulin isophane RxCUI1605101 IN; human NPH subcutaneous suspension label bridge.
- Medication form and route
- subcutaneous insulin isophane; oral supplement
What remains uncertain
- No exact event rate or arbitrary dose adjustment.
Factors that may matter: Product; Dose; Meals; Other diabetes treatment.
Read the supporting source summaries
Source 1: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: Patients prescribed human NPH insulin
Hypoglycemia can be severe. Niacin may reduce glucose lowering. Changes in glucose-active treatments and meals can require monitoring and clinician review. Intravenous and pump use prohibited.
How this applies: RxCUI1605101 IN insulin isophane; human NPH formulation bridge explicit.
Human NPH labels inform the generic insulin-isophane ingredient. Not animal insulin, rapid analogs or automatically every premix. No herb-specific event rate.
Source 2: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: Patients prescribed human NPH insulin
Hypoglycemia can be severe. Niacin may reduce glucose lowering. Changes in glucose-active treatments and meals can require monitoring and clinician review. Intravenous and pump use prohibited.
How this applies: RxCUI1605101 IN insulin isophane; human NPH formulation bridge explicit.
Human NPH labels inform the generic insulin-isophane ingredient. Not animal insulin, rapid analogs or automatically every premix. No herb-specific event rate.
Source 3: original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 27insulin-dependent diabetes patients given GS4.
Insulin needs and glucose measures decreased with GS4; glycosylated measures remained above controls.
How this applies: Exact insulin isophane and oral supplement preparation boundaries retained.
Abstract does not identify NPH, establish hypoglycemia incidence or test spacing. Proposed beta-cell recovery is a hypothesis, not proof.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Prepared exact isophane article with human NPH product bridge and source-specific clinical limits. | |
| Research summary published |
Article revision: 3de4bf8cb330677c
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.